Article Details
Retrieved on: 2022-01-23 13:00:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA is considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron ...
Article found on: abc7ny.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here